The trading price of China SXT Pharmaceuticals Inc (NASDAQ:SXTC) floating higher at last check on current market day and closing at $0.44, 18.38% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $0.41 and $0.465. The company’s P/E ratio in the trailing 12-month period was 0.20, while its 5Y monthly beta was 1.163. In examining the 52-week price action we see that the stock hit a 52-week high of $6.39 and a 52-week low of $0.36. Over the past month, the stock has lost -7.79% in value.
China SXT Pharmaceuticals Inc, whose market valuation is $1.55 million at the time of this writing, is expected to release its quarterly earnings report in January. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0 per share this quarter, however they have predicted annual earnings per share of 0 for current year and 0 for next year.
On the technical side, indicators suggest SXTC has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that SXTC’s price is currently 8.25% off the SMA20 and -16.82% off the SMA50. The RSI metric on the 14-day chart is currently showing 49.68, and weekly volatility stands at 8.30%. When measured over the past 30 days, the indicator reaches 8.78%. China SXT Pharmaceuticals Inc (NASDAQ:SXTC)’s beta value is currently sitting at 1.11, while the Average True Range indicator is currently displaying 0.04.
To see how China SXT Pharmaceuticals Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: SXTC stock’s performance was 18.38% at last check in today’s session, and -79.53% in the past year. China SXT Pharmaceuticals Inc has a P/E ratio of 0.20.
An evaluation of the daily trading volume of China SXT Pharmaceuticals Inc (NASDAQ:SXTC) indicates that the 3-month average is 596.13K. However, this figure has increased over the past 10 days to an average of 0.12.
Currently, records show that 3.48 million of the company’s shares remain outstanding. The insiders hold 1.42% of outstanding shares, whereas institutions hold 1.35%. The stats also highlight that short interest as of 2024-11-15, stood at 66958.0 shares, resulting in a short ratio of 0.22 at that time. From this, we can conclude that short interest is 171.00 of the company’s total outstanding shares. It is noteworthy that short shares in November were down slightly from the previous month’s figure, which was 0.2 million. However, since the stock’s price has seen -88.97% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
